Helen Usansky
Impact in
- Biochemistry top 5%
- Sulfur Compounds in Biology
- Dermatology top 5%
- Dermatology and Skin Diseases
Papers in
-
- Melanoma and MAPK Pathways 3
- Glycosylation and Glycoproteins Research 1
-
- Pulmonary Hypertension Research and Treatments 2
- Co-authors
- Patrick J. Sinko (4 shared papers)Brahm Goldstein (2 shared papers)Csaba Szabó (1 shared paper)Edward A. Wintner (1 shared paper)Michael A. Insko (1 shared paper)Michael Cooreman (1 shared paper)Thomas L. Deckwerth (1 shared paper)Christopher F. Toombs (1 shared paper)
- Journals
- British Journal of Dermatology (2 papers)British Journal of Clinical Pharmacology (2 papers)Molecular Cancer Therapeutics (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Molecular Cancer Research (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Helen Usansky
15 papers receiving 383 citations
Peers
Comparison fields: 5 of 78
- Biochemistry 78
- Dermatology 87
- Immunology and Allergy 45
- Pharmaceutical Science 35
- Endocrine and Autonomic Systems 31
Countries citing papers authored by Helen Usansky
This map shows the geographic impact of Helen Usansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Usansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Usansky more than expected).
Fields of papers citing papers by Helen Usansky
This network shows the impact of papers produced by Helen Usansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Usansky. The network helps show where Helen Usansky may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen Usansky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 107 | |
| 2 | 2019 | 104 | |
| 3 | 2005 | 52 | |
| 4 | 2008 | 28 | |
| 5 | 2004 | 25 | |
| 6 | 2012 | 23 | |
| 7 | 2021 | 19 | |
| 8 | 2022 | 13 | |
| 9 | 2003 | 11 | |
| 10 | 2025 | 4 | |
| 11 | 2019 | 4 | |
| 12 | 2024 | 3 | |
| 13 | 2020 | 2 | |
| 14 | 2018 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2018 | 1 | |
| 17 | 2019 | 0 |
About Helen Usansky
Helen Usansky is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Pediatrics, Perinatology and Child Health and Dermatology, having authored 17 papers that have together received 398 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Dermatology and Skin Diseases (2 papers), Pulmonary Hypertension Research and Treatments (2 papers), Computational Drug Discovery Methods (2 papers), Chronic Myeloid Leukemia Treatments (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Biochemistry (78 citations), Dermatology (87 citations), Immunology and Allergy (45 citations), Pharmaceutical Science (35 citations) and Endocrine and Autonomic Systems (31 citations). Helen Usansky has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Patrick J. Sinko, Brahm Goldstein, Csaba Szabó, Edward A. Wintner, Michael A. Insko, Michael Cooreman, Thomas L. Deckwerth, Christopher F. Toombs, Khurram Jamil and Peidi Hu. Their work appears in journals such as British Journal of Dermatology, British Journal of Clinical Pharmacology, Molecular Cancer Therapeutics, Journal of Pharmacology and Experimental Therapeutics and Molecular Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.